Kinga Ostrowska (K Ostrowska)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 6

Top Topics

Neoadjuvant Chemotherapy

Molecular Dynamics Simulations

Binding Protein

Top Venues

International journal of molecular sciences

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Kinga Ostrowska, Anna Leśniak, Weronika Gryczka, Łukasz Dobrzycki, Magdalena Bujalska-Zadrożny, Bartosz Trzaskowski
New Piperazine Derivatives of 6-Acetyl-7-hydroxy-4-methylcoumarin as 5-HT 1A Receptor Agents. International journal of molecular sciences 24 (3) (2023)
Kinga Ostrowska, Anna Leśniak, Weronika Gryczka, Łukasz Dobrzycki, Magdalena Bujalska-Zadrożny, Bartosz Trzaskowski
New Piperazine Derivatives of 6-Acetyl-7-hydroxy-4-methylcoumarin as 5-HT 1A Receptor Agents. International journal of molecular sciences 24 (3) (2023)
Kinga Ostrowska, Anna Leśniak, Weronika Gryczka, Łukasz Dobrzycki, Magdalena Bujalska-Zadrożny, Bartosz Trzaskowski
New Piperazine Derivatives of 6-Acetyl-7-hydroxy-4-methylcoumarin as 5-HT 1A Receptor Agents. International journal of molecular sciences 24 (3) (2023)
Olga Michalak, Marcin Cybulski, Wojciech Szymanowski, Agnieszka Gornowicz, Marek Kubiszewski, Kinga Ostrowska, Piotr Krzeczyński, Krzysztof Bielawski, Bartosz Trzaskowski, Anna Bielawska
Synthesis, Biological Activity, ADME and Molecular Docking Studies of Novel Ursolic Acid Derivatives as Potent Anticancer Agents. International journal of molecular sciences 24 (10) (2023)
Kinga Ostrowska, Anna Leśniak, Zuzanna Czarnocka, Jagoda Chmiel, Magdalena Bujalska-Zadrożny, Bartosz Trzaskowski
Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT1A Serotonin Receptor Antagonists. Pharmaceuticals (Basel, Switzerland) 14 (3) (2021)
Kinga Ostrowska, D Grzeszczuk, M Głuch-Lutwin, A Gryboś, A Siwek, Ł Dobrzycki, Bartosz Trzaskowski
Development of selective agents targeting serotonin 5HT1A receptors with subnanomolar activities based on a coumarin core. MedChemComm 8 (8) (2017)